Atea Historical Balance Sheet
AVIR Stock | USD 3.89 0.22 5.99% |
Trend analysis of Atea Pharmaceuticals balance sheet accounts such as Other Current Liab of 20.6 M, Total Current Liabilities of 57 M or Total Stockholder Equity of 434.1 M provides information on Atea Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Atea Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Atea Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Atea Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atea Pharmaceuticals is a good buy for the upcoming year.
Atea |
About Atea Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Atea Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Atea Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Atea Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Atea currently owns. An asset can also be divided into two categories, current and non-current.
Atea Pharmaceuticals Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Atea Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atea Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most accounts from Atea Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Atea Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.At this time, Atea Pharmaceuticals' Property Plant And Equipment Gross is relatively stable compared to the past year. As of 06/04/2024, Accumulated Other Comprehensive Income is likely to grow to about 217.3 K, while Other Current Liabilities is likely to drop slightly above 20.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 52.3M | 15.2M | 27.4M | 20.6M | Total Assets | 772.9M | 666.7M | 595.0M | 541.8M |
Atea Pharmaceuticals balance sheet Correlations
Click cells to compare fundamentals
Atea Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atea Pharmaceuticals balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Other Current Liab | 1.9M | 14.4M | 52.3M | 15.2M | 27.4M | 20.6M | |
Total Current Liabilities | 2.4M | 315.8M | 56.9M | 18.5M | 32.4M | 57.0M | |
Total Stockholder Equity | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Other Liab | 95K | 36K | 5.9M | 5.3M | 6.0M | 6.3M | |
Net Tangible Assets | (49.6M) | 547.8M | 710.1M | 640.6M | 736.7M | 398.8M | |
Property Plant And Equipment Net | 41K | 48K | 23K | 4.1M | 3.1M | 3.3M | |
Net Debt | (21.7M) | (850.1M) | (764.2M) | (643.6M) | (141.4M) | (148.5M) | |
Retained Earnings | (54.2M) | (65.2M) | 56.0M | (59.9M) | (195.8M) | (186.0M) | |
Accounts Payable | 548K | 60K | 4.5M | 2.6M | 4.3M | 2.3M | |
Cash | 21.7M | 850.1M | 764.4M | 646.7M | 143.8M | 136.6M | |
Cash And Short Term Investments | 21.7M | 850.1M | 764.4M | 646.7M | 578.1M | 530.8M | |
Common Stock Shares Outstanding | 82.6M | 82.4M | 88.2M | 83.2M | 83.4M | 85.7M | |
Liabilities And Stockholders Equity | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Non Current Liabilities Total | 69.2M | 36K | 5.9M | 7.7M | 7.4M | 7.0M | |
Other Current Assets | 249K | 7.5M | 8.0M | 14.2M | 12.3M | 7.8M | |
Other Stockholder Equity | 4.6M | 612.9M | 654.0M | 701.1M | 750.7M | 500.0M | |
Total Liab | 71.6M | 315.8M | 62.8M | 26.1M | 39.8M | 78.3M | |
Net Invested Capital | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Property Plant And Equipment Gross | 41K | 48K | 184K | 4.4M | 3.8M | 4.0M | |
Total Current Assets | 21.9M | 863.5M | 772.4M | 660.9M | 590.5M | 539.7M | |
Accumulated Other Comprehensive Income | (69.1M) | (863.6M) | 0.0 | (684K) | 207K | 217.4K | |
Net Working Capital | 19.5M | 547.7M | 715.5M | 642.4M | 558.1M | 461.3M | |
Property Plant Equipment | 41K | 48K | 23K | 4.1M | 4.7M | 4.9M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.